Which automated insulin pump keeps blood sugar tightest? study pits top systems Head-to-Head
NCT ID NCT06834334
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at 189 adults with type 1 diabetes who used one of three advanced hybrid closed-loop insulin pump systems: Medtronic Minimed 780G, Tandem T Slim X2, or CamAPS Fx. The goal was to see which system helped patients keep their blood sugar in a very tight range (70-140 mg/dL) for the longest time each day. Researchers also measured time in standard range, time above and below range, and other glucose control metrics. Since this is an observational study, it provides real-world insights but cannot prove one system is definitively better than another.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Advanced hybrid closed-loop systems (Medtronic Minimed 780G, Tandem T Slim X2, CamAPS Fx)
- What this could lead to
- If successful, this study could show which automated insulin pump system helps people with type 1 diabetes keep their blood sugar in a very tight healthy range, potentially reducing long-term complications.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be influenced by patient differences. It also only looks at short-term glucose data, not long-term health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Badajoz University Hospital
Badajoz, Badajoz, 06080, Spain
-
Ciudad Real General University Hospital
Ciudad Real, Ciudad Real, 13005, Spain
-
Hospital Universitario Mutua de Tarrasa
Terrassa, Barcelona, 08221, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Open-Source insulin systems match commercial ones without meal announcements?
- A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?
- AI takes the wheel: could a smart algorithm optimize insulin pumps from home?
- Could a metabolic modulator help people with type 1 diabetes use insulin better?
- Immune cell study may unlock kidney protection in type 1 diabetes
- Could an arthritis drug stop type 1 diabetes before it starts?